Single Intravenous Dose Dalbavancin Pathway for the Treatment of Acute Bacterial Skin and Skin Structure Infections: Considerations for Emergency Department Implementation and Cost Savings.

Frank LoVecchioMatthew W McCarthyXiaolan YeAlasdair D HenryQuan V DoanJohn L LockTodd RiccobeneRosie D LylesDavid A Talan

Published in: The Journal of emergency medicine (2024)

The new single-dose dalbavancin ED pathway for ABSSSI treatment, which was previously implemented at 11 U.S. EDs, offers robust cost savings compared to inpatient usual care.

Keyphrases

emergency department
healthcare
palliative care
primary care
quality improvement
soft tissue
high dose
intensive care unit
pain management
combination therapy
wound healing
low dose
chronic pain
hepatitis b virus
extracorporeal membrane oxygenation
replacement therapy
smoking cessation